Estradiol therapy
Showing 1 - 25 of >10,000
Transgender Women Trial in Pathum Wan (Estradiol, Estradiol and Anti-Androgen, No intervention)
Completed
- Transgender Women
- Estradiol
- +2 more
-
Pathum Wan, Bangkok, ThailandFaculty of Sports Science, Chulalongkorn University
Nov 2, 2023
COVID-19, Hormone Replacement Therapy Trial in Istanbul (Climara 0.1Mg/24Hr Transdermal System, Hydrogel patch)
Completed
- COVID-19
- Hormone Replacement Therapy
- Climara 0.1Mg/24Hr Transdermal System
- Hydrogel patch
-
Istanbul, TurkeyIstanbul University-Cerrahpasa
Mar 23, 2023
Cerebral Small Vessel Diseases, Postmenopausal Symptoms, Mild Cognitive Impairment Trial in Beijing (Estradiol Gel, Estradiol
Not yet recruiting
- Cerebral Small Vessel Diseases
- +3 more
- Estradiol Gel
- +3 more
-
Beijing, ChinaBeijing Tiantan Hospital
Aug 6, 2023
Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)
Active, not recruiting
- Metastatic Breast Cancer
- 17B-estradiol
- +3 more
-
Springfield, Massachusetts
- +2 more
Nov 1, 2022
Transgender Health, Gender Dysphoria, Transgender Women Trial in Philadelphia (Doravirine/Lamivudine/Tenofovir, Spironolactone
Completed
- Transgender Health
- +3 more
- Doravirine/Lamivudine/Tenofovir
- +3 more
-
Philadelphia, PennsylvaniaClinical Research Unit at Thomas Jefferson University
Feb 1, 2023
Overactive Bladder Syndrome Trial run by the (Vaginal estrogen, Mirabegron 50 MG [Myrbetriq])
Recruiting
- Overactive Bladder Syndrome
- Vaginal estrogen
- Mirabegron 50 MG [Myrbetriq]
-
Bethesda, MarylandWalter Reed National Military Medical Center
Nov 3, 2022
Primary Ovarian Insufficiency Trial in Moscow (Transdermal estradiol gel 0.1% 1.5mg/ day, Transdermal estradiol gel 0.1% 2.0mg/
Active, not recruiting
- Primary Ovarian Insufficiency
- Transdermal estradiol gel 0.1% 1.5mg/ day
- Transdermal estradiol gel 0.1% 2.0mg/ day
-
Moscow, Russian FederationFederal State Budget Institution Research Center for Obstetrics,
Feb 26, 2023
Muscle, Fat and Tissue Receptors
Active, not recruiting
- Gender Incongruence
- Transgenderism
- testosterone cypionate
- Estradiol Valerate
-
Saint Louis, MissouriSaint Louis Univeristy
Jan 13, 2023
Covid19 Trial in New Orleans (Placebo injection and pill, Estradiol Cypionate 5 MG/ML, Progesterone 200 MG Oral Capsule)
Completed
- Covid19
- Placebo injection and placebo pill
- +2 more
-
New Orleans, LouisianaTulane University Medical Center
Jul 19, 2022
MYFEMBREE®: A Retrospective Cohort Study UsingAdministrative
Not yet recruiting
- Pregnancy Related
- +2 more
- Relugolix + Estradiol + Norethindrone Acetate
- (no location specified)
Feb 13, 2023
Covid-19 Trial in Mexico City (Estrogen Therapy)
Active, not recruiting
- Covid-19
- Estrogen Therapy
-
Mexico City, Benito Juárez, MexicoCMN "20 de Noviembre"
Jul 7, 2022
PTSD Trial in Philadelphia (Estradiol, Placebo oral tablet)
Recruiting
- PTSD
- Estradiol
- Placebo oral tablet
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Perelman School of Medicine
Jan 30, 2023
Atrophic Vaginitis, Breast Cancer Trial in United States (Vagifem® (vaginal 17ß-estradiol) questionnaire & menopause symptom
Active, not recruiting
- Atrophic Vaginitis
- Breast Cancer
- Vagifem® (vaginal 17β-estradiol) questionnaire & menopause symptom checklist
-
Basking Ridge, New Jersey
- +4 more
Oct 18, 2022
Hiv, Prophylaxis, Transgender Trial in Baltimore (Truvada alone, Truvada plus Leuprolide, Truvada plus Estradiol 1 mg)
Recruiting
- Hiv
- +2 more
- Truvada alone
- +4 more
-
Baltimore, MarylandJohns Hopkins School of Medicine Drug Development Unit
Mar 8, 2022
Infertility, Fertility Issues, Infertility, Female Trial in Abu Dhabi, Dubai (diagnostic test, drug, procedure)
Not yet recruiting
- Infertility
- +2 more
- Transvaginal ultrasound
- +5 more
-
Abu Dhabi, United Arab Emirates
- +1 more
Aug 6, 2023
Drug Interaction Trial in Bangkok (Estradiol valerate 2 mg, cyproterone acetate 25 mg)
Active, not recruiting
- Drug Interaction
- Estradiol valerate 2 mg, cyproterone acetate 25 mg
-
Bangkok, Pathumwan, ThailandInstitute of HIV Research and Innovation (IHRI)
Oct 19, 2022
Sleep Disturbances and Insomnia Trial in Cairo (Resistive exercise)
Recruiting
- Sleep Disturbances and Insomnia
- Resistive exercise
-
Cairo, EgyptProfessor of physical therapy
Sep 23, 2022
Infertility Trial in Brussel (Longer administration of estradiol (Progynova®))
Completed
- Infertility
- Longer administration of estradiol (Progynova®)
-
Brussel, BelgiumUniversitair Ziekenhuis Brussel
Sep 28, 2021
Perimenopausal Disorder, Hot Flashes Trial in Moscow (Femoston® 1, Femoston® 2, Duphaston, Klimadynon)
Recruiting
- Perimenopausal Disorder
- Hot Flashes
- Femoston® 1, Femoston® 2
- +3 more
-
Moscow, Russian FederationFederal State Budget Institution "National Medical Research Cent
Dec 15, 2021
Menopausal Syndromes Trial in Banqiao (Tibolone, Estradiol & medroxyprogesterone acetate)
Completed
- Menopausal Syndromes
- Tibolone
- Estradiol & medroxyprogesterone acetate
-
Banqiao, New Taipei, TaiwanFar Eastern Memorial Hospital
Feb 7, 2022
HRT on Overactive Bladder Symptoms, Sexual Function, Depressive
Recruiting
- Menopausal Syndrome
- Tibolone 2.5 mg
- Estradiol valerate 1 mg/medroxyprogesterone acetate 2.5 mg
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jan 29, 2023
Cardiovascular Risk Reduction Trial in Rochester (Estradiol 100 Micrograms Patch, Estradiol Patch)
Recruiting
- Cardiovascular Risk Reduction
- Estradiol 100 Micrograms Patch
- Estradiol Patch
-
Rochester, MinnesotaMayo Clinic
Oct 13, 2021